• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C .

作者信息

D'Silva Kristin M, Serling-Boyd Naomi, Hsu Tiffany Y-T, Sparks Jeffrey A, Wallace Zachary Scott

机构信息

Division of Rheumatology, Allergy, and Immunology, Harvard Medical School, Boston, Massachusetts, USA.

Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Ann Rheum Dis. 2023 Jun;82(6):e131. doi: 10.1136/annrheumdis-2021-220166. Epub 2021 Mar 10.

DOI:10.1136/annrheumdis-2021-220166
PMID:33692020
Abstract
摘要

相似文献

1
Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C .对C.所著《关于“风湿性疾病患者感染COVID-19后针对SARS-CoV-2的抗体反应”的通信》的回应
Ann Rheum Dis. 2023 Jun;82(6):e131. doi: 10.1136/annrheumdis-2021-220166. Epub 2021 Mar 10.
2
Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'.关于“风湿性疾病患者感染 COVID-19 后对 SARS-CoV-2 的抗体反应”的通信
Ann Rheum Dis. 2023 Jun;82(6):e130. doi: 10.1136/annrheumdis-2021-220148. Epub 2021 Mar 10.
3
Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case-control study (COVID-19VacRTX).在接受利妥昔单抗治疗的炎症性风湿病患者中 COVID-19 疫苗的体液免疫原性：一项病例对照研究（COVID-19VacRTX）。
Rheumatology (Oxford). 2022 Oct 6;61(10):3912-3918. doi: 10.1093/rheumatology/keac036.
4
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis.炎症性风湿病患者在使用疾病修正抗风湿药物治疗的情况下对 SARS-CoV-2 疫苗接种的血清学反应：一项队列研究和荟萃分析。
Joint Bone Spine. 2022 Oct;89(5):105380. doi: 10.1016/j.jbspin.2022.105380. Epub 2022 Apr 28.
5
Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination.COVID-19 疫苗初始接种后，全身性风湿性疾病患者低 Spike 抗体反应的预测因素。
Clin Rheumatol. 2023 Jun;42(6):1695-1700. doi: 10.1007/s10067-023-06512-z. Epub 2023 Jan 19.
6
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.风湿性疾病患者对SARS-CoV-2疫苗接种的抗体反应减弱。
J Infect. 2022 Feb;84(2):e22-e23. doi: 10.1016/j.jinf.2021.12.006. Epub 2021 Dec 15.
7
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease.风湿性疾病患者感染新冠病毒后对严重急性呼吸综合征冠状病毒2的抗体反应。
Ann Rheum Dis. 2021 Jun;80(6):817-819. doi: 10.1136/annrheumdis-2020-219808. Epub 2021 Jan 12.
8
Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment.分析生物治疗下风湿病理患者对 SARS-CoV-2 疫苗接种产生体液免疫反应的相关因素。
Reumatol Clin (Engl Ed). 2023 Dec;19(10):565-570. doi: 10.1016/j.reumae.2023.05.008. Epub 2023 Nov 25.
9
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.疫苗类型和免疫抑制治疗，但不是诊断，对风湿性疾病患者 COVID-19 疫苗接种后的抗体反应有重要影响。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002650.
10
Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff .对韦斯托夫的《关于“利妥昔单抗治疗患者的SARS-CoV-2疫苗接种：体液免疫受损但细胞免疫可诱导的证据”的通信》的回复
Ann Rheum Dis. 2021 Oct;80(10):e163. doi: 10.1136/annrheumdis-2021-220764. Epub 2021 Jul 16.